The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer

DAlimonte Laura; Helou Joelle; Sherman Christopher; Loblaw Andrew; Chung Hans T.; Ravi Ananth; Deabreu Andrea; Zhang Liying; Morton Gerard

首页> 外文期刊>Brachytherapy >The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer

【24h】

The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer

机译：高剂量率近距离放射疗法对中危前列腺癌术后持久性癌细胞进行前列腺穿刺活检的临床意义

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PURPOSE: To evaluate the association between post-treatment biopsy results and the probability of biochemical disease-free survival (bDFS).

机译：目的：评估治疗后活检结果与生化无病生存率（bDFS）之间的关联。

著录项

来源
《Brachytherapy》 |2015年第3期|共6页
作者
DAlimonte Laura; Helou Joelle; Sherman Christopher; Loblaw Andrew; Chung Hans T.; Ravi Ananth; Deabreu Andrea; Zhang Liying; Morton Gerard;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
HDR brachytherapy; Prostate; Biochemical outcomes; Biopsy;

机译：HDR近距离放射治疗;前列腺;生化结果;活检;

相似文献

外文文献
中文文献
专利

1. Commentary on "The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer" [J] . Crook Juanita Brachytherapy . 2015,第3期

机译：关于“高剂量率近距离放射治疗对中危前列腺癌的影响，持续性前列腺癌细胞对前列腺活检的临床意义”评论
2. Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients [J] . MarinaO., GustafsonG.S., KestinL.L., Brachytherapy . 2014,第1期

机译：在现代的中危前列腺癌患者队列中，以剂量为导向，以图像为导向的放射疗法与以剂量为导向，高剂量率近距离放射疗法的比较
3. Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy. [J] . Ken Yoshida, Hideya Yamazaki, Satoaki Nakamura, Anticancer Research: International Journal of Cancer Research and Treatment . 2014,第6期

机译：新型风险分类方法的作用，前列腺癌风险指数（PRIX）在高剂量间质近距离放射治疗作为单一疗法后的临床局部局部前列腺癌。
4. Robust Evolutionary Bi-objective Optimization for Prostate Cancer Treatment with High-Dose-Rate Brachytherapy [C] . Marjolein C. van der Meer, Arjan Bel, Yury Niatsetski, International conference on parallel problem solving from nature . 2020

机译：高剂量率近距离放射治疗前列腺癌的鲁棒进化双目标优化
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Low-/high-dose-rate brachytherapy boost in patients with intermediate-risk prostate cancer treated with radiotherapy: long-term results from a single institution team experience [O] . Silvia Rodríguez Villalba, Paula Monasor Denia, Maria Jose Pérez-Calatayud, 2021

机译：用放射治疗的中间风险前列腺癌患者的低/高剂量速率近距离放射治疗：由单一机构团队经验的长期结果
7. Highly Favorable Preliminary Clinical and Toxicity Outcomes for Low- and Intermediate-Risk Prostate Cancer Patients Treated With High-Dose-Rate Brachytherapy in a Single Fraction of 19 Gy [O] . D.J. Krauss, A.A. Martinez, H. Ye, 2015

机译：对于低剂量速率近距离放射治疗的低剂量速率近距离放射治疗的高剂量速率癌症患者的高良好初步临床和毒性结果

The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅